Why the study?
Does Wenxin Keli reduce the frequency of premature ventricular contractions in patients with frequent PVCs without structural heart disease?
Population
1200 patients with frequent premature ventricular contractions without structural heart diseases, Chinese…
Comparison
Wenxin Keli for 4 weeks vs Placebo for 4 weeks
Design
RCT, 1:1 ratio, double-blind, placebo-controlled
Follow-up
4 weeks
Authors
Loading...
Supports Wenxin Keli for PVC reduction in patients without structural heart disease; confirms benefit in this 4-week RCT.
Does Wenxin Keli reduce the frequency of premature ventricular contractions in patients with frequent PVCs without structural heart disease?
Wenxin Keli effectively reduces the frequency of premature ventricular contractions and alleviates related symptoms in patients without structural heart disease over a 4-week period.
Hua et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: